Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05353036 · ClinicalTrials.gov registry record
Survey to Identify Substance Use in Teenagers and Adolescents
A clinical trial, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 250
- Enrollment target
NCT05353036: Completed study, sponsored by Nationwide Children's Hospital.
NCT05353036 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05353036 has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
This is a prospective survey study of patients 12-21 years undergoing anesthetic care. The primary objective is to determine the incidence of illicit substance use and abuse prior to anesthetic care. The secondary objective is to determine the illicit substances used and their frequency in patients presenting for anesthetic care.
Primary Outcome
As part of standard of care, nurses contact the parents of children scheduled for surgery to obtain health history and any alcohol, drug, vaping and tobacco usage. For the study, adolescents were asked to complete a survey on REDCap regarding their alcohol, drug, vaping and tobacco usage and those responses were compared to the answers the parents gave to the nurses during pre-op phone call.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-05-27 |
| Est. Completion | 2022-07-15 |
What the finished NCT05353036 record still lists
NCT05353036 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT05353036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05353036 about?
NCT05353036 is a clinical study titled "Survey to Identify Substance Use in Teenagers and Adolescents". This is a prospective survey study of patients 12-21 years undergoing anesthetic care. The primary objective is to determine the incidence of illicit substance use and abuse prior to anesthetic care. The secondary objective is to determine the illicit substances used and their frequency in patients ...
What is the current status of trial NCT05353036?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2022-05-27. Estimated completion is 2022-07-15.
What interventions are being tested in trial NCT05353036?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT05353036?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI